Analysis of risk factors influencing outcomes after unrelated cord blood transplantation in children with juvenile myelomonocytic leukaemia. An Eurocord, EBMT, EWOG-MDS, CIBMTR Study
O169
Crotta, A.
Rocha, V.
Eapen, M.
Wagner, J. E.
MacMillan, M. L.
Zecca, M.
Kurtzberg, J.
Bonfim, C.
Vora, A.
de Heredia, Díaz C.
Mohty, M.
Teague, L.
Stein, J.
O'Brien, T. A.
Bittencourt, H.
Madureira, A.
Peters, C.
Niemeyer, C.
Gluckman, E.
Locatelli, F.
(1)Eurocord Registry (Paris, FR); (2)Center for International Blood and Marrow Transplant Research (Milwaukee, US); (3)University of Minnesota (Minneapolis, US); (4)Fondazione IRCCS Policlinico San Matteo (Pavia, IT); (5)Duke University Medical Center (Durham, US); (6)Federal University of Parana (Curitiba, BR); (7)Sheffield Children's Hospital (Sheffield, UK); (8)Hospital Vall d'Hebron (Barcelona, ES); (9)University of Nantes (Nantes, FR); (10)Starship Hospital (Auckland, NZ); (11)Schneider Children's Medical Center of Israel (Petah-Tikva, IL); (12)Children's Hospital (Sydney, AU); (13)Centre Hospitalier Universitaire Sainte-Justine (Montreal, CA); (14)Instituto Nacional de Cancer (INCA) (Rio de Janeiro, BR); (15)St-Anna Kinderspital (Vienna, AT); (16)University Children's Hospital (Freiburg, DE); (17)University of Pavia (Rome, IT)
